Washington Post columnists Jonathan Capehart and Michael Gerson join William Brangham to discuss the politics of the week including the Taliban’s march across Afghanistan, the latest startling report on climate change and how to convince all Americans to get vaccinated.
According to a speech scheduled to be delivered today, the Director of the National Economic Council, Brian Deese, will say the economic disruption of the pandemic shows that America needs an industrial policy that invests in more manufacturing jobs.
- Plus, the Biden administration says it won’t meet its July 4th COVID vaccination goal.
- And, what you need to know one month ahead of the Tokyo Olympics.
Guests: Axios’ Hans Nichols and Ina Fried.
A growing number of colleges around the country will require students to get Covid-19 vaccinations before returning to campus. But the policies are igniting a debate over whether businesses and institutions like schools can make vaccines a condition of attendance. Photo: Northeastern University
Israel says it’s on track to vaccinate everyone over 16 by the end of March. To understand how the small country has vaccinated more of its population than any other so quickly, WSJ visited clinics that are giving shots to young and middle-aged citizens. Photo: Tamir Elterman for The Wall Street Journal
Joe Biden officially captures enough electoral votes to win the presidency, William Barr to resign as Attorney General, and Florida man pays neighbors’ utility bills for 2nd straight Christmas.
Rocket scientist-turned-immunology expert Mark Kendall talks about his Nanopatch, which could revolutionise vaccinations and eradicate some diseases.
Mark Kendall (born 1972) is an Australian biomedical engineer and innovator. He is an Entrepreneurial Professor of the Australian National University. His field of research is the delivery of immunotherapeutics to the skin without the use of a needle or syringe.
In 2011, he co-founded the development company Vaxxas with an investor syndicate. The company’s technology, called Nanopatch, is intended to serve as a needle-free vaccine delivery device. In 2011, Kendall and his AIBN team received the Australian Research Council Eureka Prize for Excellence in Research by an Interdisciplinary Team. In 2012, he was awarded the Rolex Awards for Enterprise for his “pioneering efforts to expand knowledge and improve human life”.